Advertisement
Product › Details
GTL001 (ProCervix)
Next higher product group | HPV vaccine_o | |
Status | 2013-04-24 development p1 end–posit | |
Organisation | Genticel S.A. (Euronext Paris + Brussels: GTCL) | |
Today | Genkyotex S.A. (Euronext Paris + Brussels: GKTX) | |
Record changed: 2023-07-10 |
Advertisement
More documents for vaccine
- [1] CureVac N.V.. (1/5/24). "Press Release: CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform". Tübingen & Boston, MA....
- [2] CureVac N.V.. (12/19/23). "Press Release: CureVac Announces Decision of German Federal Patent Court in Broad Patent Litigation with BioNTech SE". Tübingen....
- [3] LimmaTech Biologics AG. (12/19/23). "Press Release: LimmaTech Biologics Expands Vaccine Pipeline by Licensing AbVacc’s Innovative Vaccine Candidate Against Staphylococcus aureus". Schlieren & Rockville, MD....
- [4] AstraZeneca plc. (12/12/23). "Press Release: AstraZeneca to Acquire Icosavax, Including Potential First-in-Class RSV and hMPV Combination Vaccine with Positive Phase II Data"....
- [5] Icosavax, Inc.. (12/12/23). "Press Release: Icosavax, Inc. Announces Agreement to Be Acquired by AstraZeneca". Seattle, WA....
- [6] Valneva S.E.. (11/7/23). "Press Release: Valneva to Present and Hold Investor Meetings at the Jefferies London Healthcare Conference". Saint Herblain....
- [7] CEPI. (8/29/23). "Press Release: CEPI and University of Oxford to Accelerate Vaccine Development against Disease X". Oslo & Oxford....
- [8] LimmaTech Biologics AG. (7/20/23). "Press Release: GSK Grants LimmaTech Biologics License to Develop and Commercialize Shigella Vaccine". Schlieren....
- [9] Transgene S.A.. (5/5/23). "Press Release: Transgene Announces New Leadership Structure to Accelerate the Development of its Innovative Immunotherapy Portfolio". Strasbourg....
- [10] eXmoor Pharma Concepts Ltd.. (2/22/23). "Press Release: eXmoor Pharma and Vaccine Developer Imophoron Sign Process Development Partnership". Bristol....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top